Literature DB >> 18395624

Adolescent nicotine treatment changes the response of acetylcholine systems to subsequent nicotine administration in adulthood.

Theodore A Slotkin1, Bethany E Bodwell, Ian T Ryde, Frederic J Seidler.   

Abstract

Nicotine alters the developmental trajectory of acetylcholine (ACh) systems in the immature brain, with vulnerability extending from fetal stages through adolescence. We administered nicotine to adolescent rats (postnatal days PN30-47) and then examined the subsequent response to nicotine given in adulthood (PN90-107), simulating plasma levels in smokers, and performing evaluations during nicotine treatment (PN105) and withdrawal (PN110, PN120 and PN130), as well as assessing persistent changes at 6 months of age (PN180). We measured nicotinic acetylcholine receptor (nAChR) binding, choline acetyltransferase (ChAT) activity, a marker for ACh terminals, and hemicholinium-3 (HC3) binding to the choline transporter, an index of ACh presynaptic activity. By itself, adolescent nicotine exposure evoked sex-selective deficits in cerebrocortical HC3 binding while elevating ChAT in young adulthood in striatum and midbrain. Nicotine given in adulthood produced profound nAChR upregulation lasting 2 weeks after discontinuing treatment, and decrements in cerebrocortical and striatal HC3 binding emerged during withdrawal, indicative of reduced ACh synaptic activity. For all three parameters, adolescent nicotine altered the responses to nicotine given in adulthood, producing both sensitization and desensitization that depended on sex and brain region, effects that parallel the disparate behavioral outcomes reported for these treatments. The interaction seen here for the impact of adolescent nicotine exposure on adult nicotine responses was substantially greater than that found previously for the effects of prenatal nicotine exposure on adult responses. Our findings thus reinforce the importance of adolescence as a critical period in which the future responsiveness to nicotine is programmed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18395624     DOI: 10.1016/j.brainresbull.2007.12.009

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  23 in total

1.  Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes.

Authors:  Allison B Gold; Caryn Lerman
Journal:  Hum Genet       Date:  2012-01-31       Impact factor: 4.132

2.  Adolescent nicotine exposure transiently increases high-affinity nicotinic receptors and modulates inhibitory synaptic transmission in rat medial prefrontal cortex.

Authors:  Danielle S Counotte; Natalia A Goriounova; Milena Moretti; Marek T Smoluch; Hubertus Irth; Francesco Clementi; Anton N M Schoffelmeer; Huibert D Mansvelder; August B Smit; Cecilia Gotti; Sabine Spijker
Journal:  FASEB J       Date:  2012-02-03       Impact factor: 5.191

Review 3.  Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.

Authors:  W E Melroy-Greif; J A Stitzel; M A Ehringer
Journal:  Genes Brain Behav       Date:  2015-12-23       Impact factor: 3.449

4.  Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study.

Authors:  Rebecca L Ashare; Riju Ray; Caryn Lerman; Andrew A Strasser
Journal:  Drug Alcohol Depend       Date:  2012-05-15       Impact factor: 4.492

5.  Prenatal nicotine exposure enhances the trigeminocardiac reflex via serotonin receptor facilitation in brainstem pathways.

Authors:  C Gorini; H Jameson; A L Woerman; D C Perry; D Mendelowitz
Journal:  J Appl Physiol (1985)       Date:  2013-06-13

6.  Cholinergic transmission during nicotine withdrawal is influenced by age and pre-exposure to nicotine: implications for teenage smoking.

Authors:  Luis M Carcoba; James E Orfila; Luis A Natividad; Oscar V Torres; Joseph A Pipkin; Patrick L Ferree; Eddie Castañeda; Donald E Moss; Laura E O'Dell
Journal:  Dev Neurosci       Date:  2014-05-15       Impact factor: 2.984

7.  Incorporating age at onset of smoking into genetic models for nicotine dependence: evidence for interaction with multiple genes.

Authors:  Richard A Grucza; Eric O Johnson; Robert F Krueger; Naomi Breslau; Nancy L Saccone; Li-Shiun Chen; Jaime Derringer; Arpana Agrawal; Michael Lynskey; Laura J Bierut
Journal:  Addict Biol       Date:  2010-07       Impact factor: 4.280

8.  Donepezil, an acetylcholinesterase inhibitor, attenuates nicotine self-administration and reinstatement of nicotine seeking in rats.

Authors:  Blake A Kimmey; Laura E Rupprecht; Matthew R Hayes; Heath D Schmidt
Journal:  Addict Biol       Date:  2012-12-12       Impact factor: 4.280

9.  Sex differences in adult cognitive deficits after adolescent nicotine exposure in rats.

Authors:  Laura R G Pickens; James D Rowan; Rick A Bevins; Stephen B Fountain
Journal:  Neurotoxicol Teratol       Date:  2013-05-12       Impact factor: 3.763

Review 10.  Translational research in nicotine dependence.

Authors:  Jill R Turner; Allison Gold; Robert Schnoll; Julie A Blendy
Journal:  Cold Spring Harb Perspect Med       Date:  2013-03-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.